Response

Journal of the National Cancer Institute

Volumn 102, Issue 5, 2010, Pages 358-

  De Kok, Inge M C M ^a   Van Ballegooijen, Marjolein ^a   Habbema, J Dik F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH INSURANCE; LETTER; METHODOLOGY; NETHERLANDS; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 77749297965     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp374     Document Type: Letter

References (3)

1. Bos JM, Postma MJ, Annemans l. Discounting health effects in pharmacoeco-nomic evaluations: current controversies. Pharmacoeconomics. 2005;23(7):639-649.
2. Claxton K, Sculpher M, Culyer A, et al. Discounting and cost-effectiveness in nIcE\ stepping back to sort out a confusion. Health Econ. 2006;15(1):1-4
3. ISPoR. country-specifc pharmacoeconomic guidelines. http://www.ispor.org/ PEguideline s/index.asp. accessed august 26, 2009.